We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Asian American Medical Group Limited is a medical care facilities business based in Australia. Asian American Medical Group shares (AJJ) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Asian American Medical Group has a trailing 12-month revenue of around $4.8 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.028 - $0.072 |
|---|---|
| 50-day moving average | $0.0383 |
| 200-day moving average | $0.0367 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.009 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.051
| 1 week (2021-10-20) | 13.33% |
|---|---|
| 1 month (2021-09-28) | 34.21% |
| 3 months (2021-07-28) | 70.00% |
| 6 months (2021-04-28) | 37.84% |
| 1 year (2020-10-27) | 82.14% |
|---|---|
| 2 years (2019-10-25) | -17.74% |
| 3 years (2018-10-26) | -57.50% |
| 5 years (2016-10-27) | -57.50% |
| Revenue TTM | $4.8 million |
|---|---|
| Gross profit TTM | $-366,325 |
| Return on assets TTM | -10.86% |
| Return on equity TTM | -26.8% |
| Profit margin | -68.17% |
| Book value | 0.027 |
| Market capitalisation | $17.2 million |
TTM: trailing 12 months
We're not expecting Asian American Medical Group to pay a dividend over the next 12 months.
Asian American Medical Group's shares were split on a 1:16 basis on 6 August 2009. So if you had owned 16 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Asian American Medical Group shares – just the quantity. However, indirectly, the new 1500% higher share price could have impacted the market appetite for Asian American Medical Group shares which in turn could have impacted Asian American Medical Group's share price.
Over the last 12 months, Asian American Medical Group's shares have ranged in value from as little as $0.028 up to $0.072. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Asian American Medical Group's is 1.4902. This would suggest that Asian American Medical Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Asian American Medical Group Limited provides specialized medical services for liver diseases in Singapore, rest of Asia, and internationally. It operates through Liver, Multi-Speciality, Management and Consultancy, and Healthcare Real Estate segments. The company provides medical consultation and services for hepatology and related fields; multi-specialty medical consultation and services for medical pilot zones in China; and healthcare management and consultancy services, as well as develops real estate projects. Asian American Medical Group Limited has a strategic collaboration with University of Pittsburgh Medical Centre. The company was formerly known as Asian Centre for Liver Diseases and Transplantation Limited and changed its name to Asian American Medical Group Limited in December 2012. Asian American Medical Group Limited was founded in 1994 and is based in Singapore.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
